Literature DB >> 3740148

Pelvic lymphadenectomy in operative treatment of ovarian cancer.

E Burghardt, H Pickel, M Lahousen, H Stettner.   

Abstract

From the end of 1979 to September, 1985, radical pelvic lymphadenectomy was performed at the Graz Clinic in 123 cases of Stages IA to IV ovarian cancer following maximum debulking procedure. In 97 patients lymphadenectomy was done primarily. In 26 it was performed during a follow-up operation to chemotherapy. The frequency of pelvic node involvement was 61.8% in the total material and 78.0% in 82 cases of Stage III disease only; 75.0% positive nodes were found in Stage III after chemotherapy. Aortic nodes were positive in 41.4%, but only when pelvic nodes were also positive. The 5-year actuarial survival rate for Stage III disease was 53.0% after pelvic lymphadenectomy compared with 13.0% without. In cases with negative nodes the survival rate was 74.7%; with positive nodes the survival rate was 45.9%.

Entities:  

Mesh:

Year:  1986        PMID: 3740148     DOI: 10.1016/0002-9378(86)90817-3

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  7 in total

Review 1.  Management of retroperitoneal lymph nodes in the treatment of ovarian cancer.

Authors:  Kimio Ushijima
Journal:  Int J Clin Oncol       Date:  2007-06-27       Impact factor: 3.402

2.  In vitro chemosensitivity testing in the treatment of ovarian carcinoma.

Authors:  H Auner; E Petru; H M Hofmann; H Pickel; P Pürstner
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

Review 3.  [The role of radical lymphadenectomy. Experiences from the AGO Ovarian Cancer Study Group].

Authors:  P Wimberger; R Kimmig
Journal:  Urologe A       Date:  2009-01       Impact factor: 0.639

4.  The relationship between retroperitoneal lymphadenectomy and survival in advanced ovarian cancer patients.

Authors:  Chenyan Fang; Yingli Zhang; Lingqin Zhao; Xi Chen; Liang Xia; Ping Zhang
Journal:  BMC Cancer       Date:  2020-07-13       Impact factor: 4.430

5.  Systematic lymphadenectomy in ovarian cancer at second-look surgery: a randomised clinical trial.

Authors:  T Dell' Anna; M Signorelli; P Benedetti-Panici; A Maggioni; R Fossati; R Fruscio; R Milani; L Bocciolone; A Buda; C Mangioni; G Scambia; R Angioli; E Campagnutta; R Grassi; F Landoni
Journal:  Br J Cancer       Date:  2012-08-02       Impact factor: 7.640

6.  The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients.

Authors:  J K Chan; R Urban; J M Hu; J Y Shin; A Husain; N N Teng; J S Berek; K Osann; D S Kapp
Journal:  Br J Cancer       Date:  2007-05-22       Impact factor: 7.640

7.  Surgical manual of the Korean Gynecologic Oncology Group: ovarian, tubal, and peritoneal cancers.

Authors:  Seob Jeon; Sung Jong Lee; Myong Cheol Lim; Taejong Song; Jaeman Bae; Kidong Kim; Jung Yun Lee; Sang Wun Kim; Suk Joon Chang; Jong Min Lee
Journal:  J Gynecol Oncol       Date:  2016-08-22       Impact factor: 4.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.